Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The objective of this long term study is to prospectively compare the incidence of NSF in two cohorts (Cohort 1- patients with moderate chronic kidney disease eGFR 30-59 and Cohort 2- patients with severe chronic kidney disease or kidney failure eGFR \<30).
Epistemonikos ID: e372bf06e5b5c46d32f3ae1ad57c69acb2cb2db3
First added on: May 04, 2024